Literature DB >> 16500429

Perioperative management of sickle cell disease children undergoing adenotonsillectomy.

Rebecca L Duke1, J Paul Scott, Julie A Panepinto, Valerie A Flanary.   

Abstract

OBJECTIVE: To determine if outpatient tailored perioperative management has the same complication rate as that previously published for sickle cell disease (SCD) children who undergo adenotonsillectomy. STUDY DESIGN AND
SETTING: Retrospective chart review of SCD children who underwent tonsillectomy with outcome measures of perioperative management and postsurgical complications.
RESULTS: Of 41 patients, 61% were monitored for <24 hours with the average length of stay being 2 days (range, 1 to 10). Postoperative complications were noted in 9 (22%) patients, including 8 (20%) with hypoxia, 4 (10%) fever, 3 (8%) acute chest syndrome, and 1 (2.4%) airway fire, which are similar to the published literature.
CONCLUSIONS: Current literature supports extensive perioperative management with hospital stays averaging 3 to 5 days. These data demonstrate that the majority of these patients can be managed with <24-hour hospitalization stays with similar complication rates as previously described in the literature. SIGNIFICANCE: This study establishes a new paradigm for perioperative management of SCD children who undergo adenotonsillectomy. EBM RATING: C-4.

Entities:  

Mesh:

Year:  2006        PMID: 16500429     DOI: 10.1016/j.otohns.2005.11.001

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  4 in total

1.  Tonsillectomy and adenoidectomy for obstructive sleep apnea in sickle cell anemia.

Authors:  Raj Warrier; A Chauhan; U Athale
Journal:  Indian J Pediatr       Date:  2010-06-08       Impact factor: 1.967

2.  Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea.

Authors:  Anthony J Grady; Jane S Hankins; Brent Haberman; Robert Schoumacher; Rose Mary Stocks
Journal:  Sleep Breath       Date:  2017-01-11       Impact factor: 2.816

3.  Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.

Authors:  A Parker Ruhl; S Christy Sadreameli; Julian L Allen; Debra P Bennett; Andrew D Campbell; Thomas D Coates; Dapa A Diallo; Joshua J Field; Elizabeth K Fiorino; Mark T Gladwin; Jeffrey A Glassberg; Victor R Gordeuk; Leroy M Graham; Anne Greenough; Jo Howard; Gregory J Kato; Jennifer Knight-Madden; Benjamin T Kopp; Anastassios C Koumbourlis; Sophie M Lanzkron; Robert I Liem; Roberto F Machado; Alem Mehari; Claudia R Morris; Folasade O Ogunlesi; Carol L Rosen; Kim Smith-Whitley; Danna Tauber; Nancy Terry; Swee Lay Thein; Elliott Vichinsky; Nargues A Weir; Robyn T Cohen; Elizabeth S Klings
Journal:  Ann Am Thorac Soc       Date:  2019-09

4.  Beneficial effects of adenotonsillectomy in children with sickle cell disease.

Authors:  Ilaria Liguoro; Michele Arigliani; Bethany Singh; Lisa Van Geyzel; Subarna Chakravorty; Cara Bossley; Maria Pelidis; David Rees; Baba P D Inusa; Atul Gupta
Journal:  ERJ Open Res       Date:  2020-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.